2021 Report on Proliferative Vitreoretinopathy (Ophthalmology) Drugs In Development – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Proliferative Vitreoretinopathy (PVR) (Ophthalmology) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Proliferative Vitreoretinopathy (Ophthalmology) pipeline landscape. Proliferative Vitreoretinopathy (PVR) occurs when a scar forms under or on the retina after retinal detachment, preventing the retina from healing and falling back into place. Risk factors for proliferative vitreoreti

Full Story →